During the past decade, Capital Nephrology Medical Group conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 6 clinical trials were completed, i.e. on average, 120% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 3 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Capital Nephrology Medical Group" #1 sponsor was "C. R. Bard" with 1 trials, followed by "Ironwood Pharmaceuticals, Inc." with 1 trials sponsored, "Keryx Biopharmaceuticals" with 1 trials sponsored, "Medtronic Endovascular" with 1 trials sponsored and "Pfizer" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Capital Nephrology Medical Group" #1 collaborator was "Hospira, now a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Medpace, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Capital Nephrology Medical Group" are "Arteriovenous Fistula" (2 trials), "Chronic Kidney Disease (CKD)" (2 trials), "Anemia" (1 trials), "Anemia of Chronic Kidney Disease" (1 trials) and "Arteriovenous Fistula Occlusion" (1 trials). Many other conditions were trialed in "Capital Nephrology Medical Group" in a lesser frequency.

Most popular intervention types in "Capital Nephrology Medical Group" are "Device" (3 trials), "Drug" (3 trials), "Biological" (1 trials), "Combination Product" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Epoetin Hospira" (1 trials), "Epogen Amgen" (1 trials), "HX575 epoetin alfa" (1 trials) and "IN.PACT AV DCB" (1 trials). Other intervention names were less common.

The vast majority of trials in "Capital Nephrology Medical Group" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Capital Nephrology Medical Group". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Capital Nephrology Medical Group, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Capital Nephrology Medical Group, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 2 trials that are defined as “Not Applicable".